5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease

Reply

(2018) Naga Chalasani et al.   HEPATOLOGY

Activation of the 12/15 lipoxygenase pathway accompanies metabolic decline in db/db pre-diabetic mice

(2018) Anca D. Dobrian et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE)

(2017) Charles Austin Pickens et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Targeted profiling of arachidonic acid and eicosanoids in rat tissue by UFLC–MS/MS: Application to identify potential markers for rheumatoid arthritis

(2017) Nannan Wang et al.   TALANTA

Lipoxin A4 exerts protective effects against experimental acute liver failure by inhibiting the NF-κB pathway

(2016) XUEQIANG JIANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Promotion of adipogenesis by 15-(S)-hydroxyeicosatetraenoic acid

(2016) Yong-Seok Song et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects

(2016) Katharina Möller et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes

(2015) Chantal Cossette et al.   BIOCHEMICAL PHARMACOLOGY

Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid

(2015) William S. Powell et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease—A pilot study

(2015) Dominika Maciejewska et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Endocrine causes of nonalcoholic fatty liver disease

(2015) Laura Marino   WORLD JOURNAL OF GASTROENTEROLOGY

The role of lipoxygenases in pathophysiology; new insights and future perspectives

(2015) Ryuichi Mashima et al.   Redox Biology

Deciphering non-alcoholic fatty liver disease through metabolomics: Figure 1

(2014) Ainara Cano et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Adipose Tissue 12/15 Lipoxygenase Pathway in Human Obesity and Diabetes

(2014) David C. Lieb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

15(S)-HETE-induced angiogenesis in adipose tissue is mediated through activation of PI3K/Akt/mTOR signaling pathway

(2013) Sasikumar J. Soumya et al.   Biochemistry and Cell Biology

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

(2012) G. Musso et al.   DIABETOLOGIA

Non-alcoholic fatty liver disease and cardiovascular risk

(2012) Angel Brea et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction

(2012) Jessica R. Weaver et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Lipidic last breath of life in patients with alcoholic liver disease

(2012) Joanna Raszeja-Wyszomirska et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease

(2011) Marcos Martínez-Clemente et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages

(2011) Ines Kämmerer et al.   Lipids in Health and Disease

Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus

(2010) Vera S. G. Ferreira et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

5-Lipoxygenase Activating Protein Signals Adipose Tissue Inflammation and Lipid Dysfunction in Experimental Obesity

(2010) R. Horrillo et al.   JOURNAL OF IMMUNOLOGY

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2010) Ariel E. Feldstein et al.   JOURNAL OF LIPID RESEARCH

The plasma lipidomic signature of nonalcoholic steatohepatitis

(2009) Puneet Puri et al.   HEPATOLOGY

Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPAR -Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke

(2009) M. Sobrado et al.   JOURNAL OF NEUROSCIENCE